Bill Text: SD HB1099 | 2026 | Regular Session | Enrolled
Bill Title: Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Sponsorship: Slight Partisan Bill (Republican 9-4)
Status: (Passed) 2026-03-10 - Signed by the Governor on March 10, 2026 H.J. 547 [HB1099 Detail]
Download: South_Dakota-2026-HB1099-Enrolled.pdf
